HOME >> BIOLOGY >> NEWS
Beware cancer, insomnia and liver disease UH students are taking aim

HOUSTON, June 1, 2004 Targeting a range of diseases and disorders, three University of Houston students won awards at a recent symposium for research in liver disease, cancer and insomnia.

The Intercultural Cancer Council (ICC) recently hosted its 9th Biennial Symposium on Minorities, the Medically Undeserved and Cancer in Washington, D.C. The ICC promotes policies, programs, partnerships and research to eliminate the unequal burden of cancer among racial and ethnic minorities and medically undeserved populations in the U.S. and its associated territories.

Among the 1,500 who attended this ICC symposium, UH students accounted for 18 of the 300 students from across the nation who participated. Three UH students from the College of Natural Sciences and Mathematics (NSM) swept the undergraduate research competition, taking home half of the six awards handed out in that category. Each received a medal to recognize their achievements and a cash award of $500.

"We are extremely proud of all our students who represented the University of Houston," said John Bear, dean of UH's College of Natural Sciences and Mathematics. "And we're particularly pleased with the acknowledgement received by our three outstanding students who presented award-winning work, as well as commend the faculty members for engaging undergraduates in the research process."

Jose Figueroa, a senior biology major in NSM's Biology and Biochemistry department at UH, won his poster award for research in biological clocks. Also known as circadian rhythms, biological clocks are the mechanisms that control sleep/wake cycles in living organisms. Working in the Neurobiology Laboratory with Michael Rea, UH professor of biology and biochemistry, Figueroa assists with the lab's focus on understanding the biological clock so that it may eventually lead to therapeutic agents that can treat sleeping/waking disorders, such as advanced sleep phase syndrome, jet lag and insomn
'"/>

Contact: Lisa Merkl
lkmerkl@uh.edu
713-743-8192
University of Houston
1-Jun-2004


Page: 1 2 3

Related biology news :

1. Beware of leap year when predicting climate change, warns researcher
2. Beware the frozen vegetable ice pack to ease pain
3. Beware The Pumpkin Preyer
4. IBD (Crohns, Colitis) joins cancer, inflammatory diseases in associated blood vessel growth
5. Purdue scientists: To stop cancer, keep your Icmt away from your Ras
6. Drug developed for rare disease may help millions more as treatment for cancer, autoimmune diseases
7. Telltale prostate cancer protein key to breast cancer, too
8. UGA receives $6.7 M grant that will add knowledge in fights against cancer, Parkinsons disease
9. Isolation of ferret protein promising for cancer, reproductive studies
10. UNC studies target molecular defects implicated in cancer, genetic diseases
11. Common human virus may be associated with colon cancer, according to Temple researchers

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Beware cancer insomnia and liver disease students are taking aim

(Date:2/5/2015)... , Jan. 26, 2015   Epic Sciences , a ... today announced that Murali Prahalad , Ph.D., president and ... World Conference (PMWC) 2015: Silicon Valley, which is taking ... View, Calif. on January 26-28, 2015. ... of Age as Biomarkers." Last year, Epic Sciences was a ...
(Date:2/5/2015)... 2015 New Market Research Reports ... Forecasts To 2020 has Been Added to GrandViewReseach.com Report ... expected to reach USD 5.10 billion by 2020, according ... IR cameras help identify the site of tissue damage ... surging demand in medical imaging applications. They have been ...
(Date:2/5/2015)... 30, 2015  It is gratifying to see that ... for genomic science as a means to better understand ... treatment.  I was honored to participate in today,s White ... program. Since the 1980s my teams ... the first sequenced genome of a free living organism, ...
Breaking Biology News(10 mins):Epic Sciences to Present at Personalized Medicine World Conference 2015 on the Use of Circulating Tumor Cells as Cancer Biomarkers 2IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 2IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 3J. Craig Venter, Ph.D., Co-Founder and CEO, Human Longevity, Inc. (HLI) Participates in White House Precision Medicine Event 2
(Date:2/27/2015)... CA (PRWEB) February 27, 2015 Cytokinetics, ... forces on February 28 with patients and health care ... awareness for Rare Disease Day®. Rare Disease Day ... and calling attention to the special challenges faced by ... them. , “Cytokinetics is proud to stand alongside patients ...
(Date:2/26/2015)... , Feb. 26, 2015 S&P Capital ... Factual Stock Report coverage on MabVax Therapeutics Holdings Inc ... is a clinical stage biotechnology company focused on the ... medical needs in the treatment of cancer. MabVax has ... on the protective immune responses generated by patients who ...
(Date:2/26/2015)... SQI Diagnostics Inc. ("SQI" or the "Company") (TSX-V: SQD; ... commercializes proprietary technologies and products for advanced microarray diagnostics, ... fiscal first quarter ended December  31, 2014. All figures ... unless otherwise stated. "During the quarter ... existing customers and add to our sales pipeline," said ...
(Date:2/26/2015)... Feb. 26, 2015 Protiviti ( www.protiviti.com ), ... of the Governance Portal , designed to increase ... compliance (GRC) tasks across multiple business units and projects. ... help customers better align their controls with the COSO ... ) requirements. In response to client feedback, Protiviti has ...
Breaking Biology Technology:Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 2Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 3Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 4Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 5Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 6S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 5SQI Diagnostics Reports First Quarter Financial Results 2SQI Diagnostics Reports First Quarter Financial Results 3SQI Diagnostics Reports First Quarter Financial Results 4SQI Diagnostics Reports First Quarter Financial Results 5SQI Diagnostics Reports First Quarter Financial Results 6Protiviti Governance Portal Helps Companies Drive Governance, Risk and Compliance Productivity Across Multiple Business Units 2Protiviti Governance Portal Helps Companies Drive Governance, Risk and Compliance Productivity Across Multiple Business Units 3
Cached News: